Debiopharm Investments & Fund Profile

Overview

Biopharmaceutical development specialist for drug candidates and licensing.

Founded

1979

Deals · 12mo

2

Links

Website LinkedIn X (Twitter)

Stage focus

Series A

Geographic focus

Canada

France

Germany

Switzerland

...

Sector focus

Biotechnology

Medical

Medical Device

Pharmaceutical

Investment portfolio

28rounds

LedParticipated

NAME	DATE	SIZE
WhiteLab Genomics	Oct 2026Participated	$26 MSeries B
ViewsML	Apr 2026Participated	$5 MSeed
StratifAI	Oct 2025Participated	$15 MOther Equity
Strategikon Pharma	Feb 2024Led	$7 MSeries A
Tune Insight	Sep 2023Participated	$3 MSeed
Altis Labs	Jun 2023Led	$6 MSeed
Genialis	Mar 2023Led	$13 MSeries A
Iktos	Mar 2023Led	$16 MSeries A
Yonalink	Nov 2022Led	$6 MOther Equity
WhiteLab Genomics	Sep 2022Participated	$10 MSeries A
Mika	May 2022Led	$11 MSeries A
VivoSense	Mar 2022Led	$25 MSeries A
WhiteLab Genomics	Oct 2026Participated	$26 MSeries B
ViewsML	Apr 2026Participated	$5 MSeed
StratifAI	Oct 2025Participated	$15 MOther Equity
Strategikon Pharma	Feb 2024Led	$7 MSeries A
Tune Insight	Sep 2023Participated	$3 MSeed
Altis Labs	Jun 2023Led	$6 MSeed
Genialis	Mar 2023Led	$13 MSeries A
Iktos	Mar 2023Led	$16 MSeries A
Yonalink	Nov 2022Led	$6 MOther Equity
WhiteLab Genomics	Sep 2022Participated	$10 MSeries A
Mika	May 2022Led	$11 MSeries A
VivoSense	Mar 2022Led	$25 MSeries A

28 Items

28

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Debiopharm: 28 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Seed	1	2
Series A	10	4
Series B	1	3
Series C+	0	4
Other Equity	2	1

Monthly Deal Activity

Debiopharm: 28 deals are recorded across 199 months. All available history
Month	Deals
Apr '10	1
May '10	0
Jun '10	0
Jul '10	0
Aug '10	0
Sep '10	0
Oct '10	0
Nov '10	0
Dec '10	0
Jan '11	1
Feb '11	0
Mar '11	0
Apr '11	0
May '11	0
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	0
Oct '11	0
Nov '11	1
Dec '11	0
Jan '12	0
Feb '12	0
Mar '12	0
Apr '12	0
May '12	1
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	0
Oct '12	0
Nov '12	0
Dec '12	1
Jan '13	1
Feb '13	0
Mar '13	0
Apr '13	0
May '13	1
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	0
Jan '14	0
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	0
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	0
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	1
Jun '17	0
Jul '17	0
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	1
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	1
Jan '20	1
Feb '20	0
Mar '20	0
Apr '20	0
May '20	0
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	1
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	1
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	1
Dec '21	0
Jan '22	1
Feb '22	0
Mar '22	2
Apr '22	0
May '22	1
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	1
Oct '22	0
Nov '22	1
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	2
Apr '23	0
May '23	0
Jun '23	1
Jul '23	0
Aug '23	0
Sep '23	1
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	1
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	1
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	1
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	1

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Debiopharm: Health & Life Sciences is the largest displayed sector by deal count (26 deals). All available history
Sector	Deals
Health & Life Sciences	26
AI & Machine Learning	8
Enterprise Software	4
Space & Frontier Tech	4
Networks, Cloud & Communication	2
Data, Analytics & IT	2
Hardware & Robotics	1
Food & Agriculture	1
AR/VR	1
Social & Community Platforms	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Debiopharm: 28 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	3
$5M-$10M	4
$10M-$25M	13
$25M-$50M	6
$50M-$100M	2
$100M-$250M	0
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 4 of 4 regions; European countries are grouped as Europe.

Debiopharm: Europe has the largest recorded deal count among the displayed regions (18 deals). All available history
Region	Deals
Europe	18
United States	7
Canada	2
Israel	1

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Debiopharm: 20 co-investors are shown, with Benaruca sharing 3 recorded deals. All available history
Co-investor	Shared deals
Benaruca	3
Johnson & Johnson Innovation	3
Korys	3
Omnes Capital	3
Aescap Venture	2
Biovest	2
New Rhein Healthcare Investors	2
Philips	2
PMV	2
Section 32	2
Tesi	2
Valiance	2
14Peaks Capital	1
Aa Sons	1
Advent Venture Partners	1
Alven	1
Ananda Impact Ventures	1
Arve Capital	1
AVP	1
Balderton Capital	1